Merck KGaA, Darmstadt, Germany, appoints Anke Schenkel as Head of Group Controlling & Risk Management
Darmstadt, Germany, February 1, 2017 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that with effect from April 1, Anke Schenkel (36) will assume the role of Head of Group Controlling & Risk Management. Schenkel will report to Marcus Kuhnert, Chief Financial Officer and member of the Executive Board of Merck KGaA, Darmstadt, Germany.
Currently Head of Forecasting, Reporting & Governance in Controlling of the company’s Healthcare business sector, Anke Schenkel will succeed Joachim Christ who will become the Group’s Chief Procurement Officer effective April 1, as announced previously.
“Our people are key to our success. We are therefore committed to developing and growing our employees and executives. I am pleased we could appoint an emerging leader with a proven track record from within our company to this important role”, said Kuhnert.
Prior to joining Merck KGaA, Darmstadt, Germany, in 2010, Schenkel held various roles at PricewaterhouseCoopers. She has a Master’s degree in business administration awarded by the University of Mainz in Germany.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck KGaA, Darmstadt, Germany, generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the „Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
MilliporeSigma today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program.